Warberg Asset Management’s The Lion Electric Company Warrants to purchase common shares LEV.WS.A Stock Holding History

Warberg Asset Management’s Portfolio LEV.WS.A Stock Details LEV.WS.A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,000	Closed	-$1.36K	–	249
2024 Q3	$1.36K	Sell	17,000 -4,000	-19%	-$356	﹤0.01%	196
2024 Q2	$3.62K	Hold	21,000	–	–	﹤0.01%	196
2024 Q1	$6.72K	Hold	21,000	–	–	﹤0.01%	174
2023 Q4	$8K	Hold	21,000	–	–	﹤0.01%	175
2023 Q3	$11K	Sell	21,000 -18,298	-47%	-$11.2K	﹤0.01%	171
2023 Q2	$18.3K	Hold	39,298	–	–	﹤0.01%	165
2023 Q1	$23.2K	Sell	39,298 -21,369	-35%	-$17.1K	﹤0.01%	163
2022 Q4	$41.9K	Buy	+60,667	New	+$35.1K	0.01%	154

Other funds holding LEV.WS.A

Skaana Management Brooklyn, New York $465M AUM 58.97% 1-Year Est. Return

Warberg Asset Management's LEV.WS.A Position: Q4 2024 in Review

Warberg Asset Management sold out of The Lion Electric Company Warrants to purchase common shares (LEV.WS.A) in Q4 2024, closing a stake of 17,000 shares — an estimated $1.36K sold.

Warberg Asset Management first reported a position in LEV.WS.A in Q4 2022 and held it in 8 quarters. The position peaked at $41.9K in Q4 2022. 1 fund tracked by Wall St. Rank holds LEV.WS.A as of Q4 2024.

Warberg Asset Management reported no remaining The Lion Electric Company Warrants to purchase common shares position as of Q4 2024 after selling out during the quarter.
Warberg Asset Management sold 17,000 The Lion Electric Company Warrants to purchase common shares shares in Q4 2024, an estimated $1.36K.
Warberg Asset Management first reported a position in The Lion Electric Company Warrants to purchase common shares in Q4 2022 and held it in 8 quarters.
Warberg Asset Management's The Lion Electric Company Warrants to purchase common shares position peaked at $41.9K in Q4 2022.
1 fund tracked by Wall St. Rank held The Lion Electric Company Warrants to purchase common shares as of Q4 2024.

Based on Warberg Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.